MAIA Biotechnology, Inc.

MAIA
$1.46 (+ $0.01 + 0.69%)
Last updated: 2026-07-07 10:48 UTC
MAIA Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS5526411021
CUSIP552641102
Market Price1.46
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.74
Market Cap$54.8M
Book Value0.0
Price to Book1480.0
Beta0.01
52w High2.74
52w Low0.87
Next Earnings DateN/A

MAIA Biotechnology, Inc. trades under ticker MAIA on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US5526411021, CUSIP 552641102.

About the Company
MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Price History